CAMEO+ eventCORPORATE2026-05-07馃嚭馃嚫
Novartis breaks ground on radioligand therapy site in Denton, Texas
source: Novartis
On 2026-05-07, Novartis broke ground on a new 46,000 sq. ft radioligand therapy manufacturing site in Denton, Texas. The company said the site is part of a broader $23 billion investment in US manufacturing and research and will expand its US RLT production network.
0.32Significance4.0Magnitude0.7Systemic0.3Market1Articles
Location
DentonTexasNorth AmericaUnited StatesNorth America33.215, -97.133
Story Links